comparemela.com

Latest Breaking News On - Richard hutchison - Page 2 : comparemela.com

Management Changes | Company Announcement

Investegate announcements from Management Changes

South africaCity ofUnited kingdomJohn reganBen listerDan dearden williamsJeremy porterBessie elliotRichard hutchisonJohn hutchinsonCharles goodwinMain market of the london stock exchangeLauren kelleher as group financialLauren kelleherGroup financial controllerElectric guitar

Adoption of Share Plans and Grant of Options | Company Announcement

Investegate announcements from Adoption of Share Plans and Grant of Options

City ofUnited kingdomJeremy porterDan dearden williamsCharles goodwinJohn hutchinsonRichard hutchisonCaroline worboysDavid eldridgeBessie elliotGrahame cookJohn reganRichard horwoodCompany ordinaryMain market of the london stock exchangeLondon stock exchange

Completion of acquisition and admission to AIM | Company Announcement

Investegate announcements from Completion of acquisition and admission to AIM

City ofUnited kingdomBessie elliotJohn reganRichard horwoodJohn hutchinsonRichard hutchisonDavid eldridgeDan dearden williamsCharles goodwinJeremy porterMain market of the london stock exchangeLondon stock exchangeCompany admission documentElectric guitarAdmission document

Update re intention to de-list | Company Announcement

Investegate announcements from Update re. intention to de-list

City ofUnited kingdomBessie elliotSarah hollinsSarfraz munshiRichard hutchisonJohn hutchinsonParty transactionSanderson capital partnersMain market of the london stock exchangeLondon stock exchangeFinancial conduct authorityOfficial listMain marketElectric guitarOrdinary shares

Appointment of Phase I Clinical Trial CRO | Company Announcement

Investegate announcements from Appointment of Phase I Clinical Trial CRO

United kingdomClarissa sowemimo cokerSimon nayyarRichard hutchisonArthur dingemansAcuitas communicationsOxford cannabinoid technologies holdingsVictoria pty ltdPty ltdOxford cannabinoid technologies holdings plcCanopy growth corporationAxis capital marketsDirectors of the companyOxford cannabinoid technologies ltdEuropean union withdrawalPhasei clinical trial

vimarsana © 2020. All Rights Reserved.